Form 4: Procept BioRobotics CFO Kevin Waters Exercises Options and Sells Shares
SEC Form 4 Filing
EVP and CFO of Procept BioRobotics, Kevin Waters, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Kevin Waters, the EVP and CFO of Procept BioRobotics, executed transactions involving the company's stock on October 15, 2024.
- Waters exercised stock options to acquire 25,000 shares of common stock at a price of $4.56 per share.
- Concurrently, Waters sold a total of 25,000 shares in multiple transactions at weighted average prices of $72.11, $73.02 and $73.75.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2024.
- Following these transactions, Waters directly owns 96,096 shares of common stock and 19,160 stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine insider trading activity under a pre-existing plan, with no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-arranged nature of the trades mitigates any significant concerns.
Key Dates
| Date | Description |
|---|---|
| December 12, 2019 | Date the stock option was granted. |
| June 13, 2024 | Date the Rule 10b5-1 trading plan was adopted. |
| October 15, 2024 | Date of the stock option exercise and share sales. |
| October 17, 2024 | Date of the Form 4 filing. |
| December 11, 2029 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.